Compare THG & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THG | MIR |
|---|---|---|
| Founded | 1852 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.7B |
| IPO Year | 1995 | N/A |
| Metric | THG | MIR |
|---|---|---|
| Price | $170.44 | $27.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $196.67 | $28.29 |
| AVG Volume (30 Days) | 315.0K | ★ 2.2M |
| Earning Date | 02-03-2026 | 02-10-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | ★ 73.14 | N/A |
| EPS | ★ 17.31 | 0.10 |
| Revenue | ★ $6,506,900,000.00 | $902,300,000.00 |
| Revenue This Year | $4.23 | $8.75 |
| Revenue Next Year | $5.18 | $23.17 |
| P/E Ratio | ★ $9.87 | $258.61 |
| Revenue Growth | 5.26 | ★ 7.82 |
| 52 Week Low | $147.76 | $12.00 |
| 52 Week High | $188.18 | $30.28 |
| Indicator | THG | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 34.20 | 65.86 |
| Support Level | $166.54 | $26.01 |
| Resistance Level | $181.04 | $27.21 |
| Average True Range (ATR) | 3.90 | 0.86 |
| MACD | -1.46 | 0.38 |
| Stochastic Oscillator | 18.35 | 99.51 |
The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.